Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 649-657     DOI: 10.31083/j.rcm2203075
Special Issue: Contemporary management of Heart Failure in association with renal outcomes and prognosis
Review Previous articles | Next articles
Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction
Ronald O. Morales1, Francesc Barbosa2, Nuria Farre1, 3, 4, *()
1Heart Failure Unit, Department of Cardiology, Hospital del Mar, 08003 Barcelona, Spain
2Department of Nephrology, Hospital del Mar, 08003 Barcelona, Spain
3Department of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
4Heart Diseases Biomedical Research Group (GREC), IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain
Download:  PDF(133KB)  ( 278 ) Full text   ( 28 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Heart failure is a significant health problem worldwide. Despite all the new therapies available nowadays, many patients will reach advanced stages of the disease. Diuretic resistance, kidney dysfunction, and refractory congestion, all highly prevalent in advanced heart failure, frequently complicate the situation, making it more challenging to manage. Ultrafiltration through hemodialysis or peritoneal dialysis can be alternative options to treat fluid overload. Peritoneal dialysis has gained increased interest in the last decades due to several benefits such as functional class improvement, reduction in hospital admissions, improvement in quality of life, and even a reduction in mortality shown by numerous cohort studies. However, the majority of the studies were observational and with a limited number of patients. In addition, the optimal timing for the initiation of this type of therapy and the subgroup of patients who would benefit the most from it is unknown. Hence, randomized controlled trials in this subject are urgently needed. We aim to review the contemporary evidence of peritoneal dialysis in patients with heart failure and diuretic resistance across the spectrum of ventricular dysfunction and degree of renal dysfunction.
Key words:  Peritoneal dialysis      Heart failure      Diuretic resistance      Fluid overload      Renal dysfunction      Ventricular dysfunction     
Submitted:  02 June 2021      Revised:  05 July 2021      Accepted:  12 July 2021      Published:  24 September 2021     
*Corresponding Author(s):  Nuria Farre     E-mail:  nfarrelopez@psmar.cat

Cite this article: 

Ronald O. Morales, Francesc Barbosa, Nuria Farre. Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction. Reviews in Cardiovascular Medicine, 2021, 22(3): 649-657.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203075     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/649

[1] Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, Claudio Ronco. Cardionephrology and cardiorenal disease in Italy: state of the art[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 563-572.
[2] Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 573-584.
[3] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[4] Sarah Fitzsimons, Robert N Doughty. Role of transthoracic echocardiogram in acute heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 741-754.
[5] Martha Kyriakou, Anastasia Samara, Katerina Philippou, Ioanna Lakatamitou, Ekaterini Lambrinou. A qualitative meta-synthesis of patients with heart failure perceived needs[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 853-864.
[6] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[7] Ali Yazdanyar, Muhammad Haisum Maqsood, Jerald Pelayo, Julien Sanon, Eduardo Quintero, Kevin Bryan Lo, Roy O. Mathew, Janani Rangaswami. Clinical outcomes in patients with heart failure with and without cirrhosis: an analysis from the national inpatient sample[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 925-929.
[8] Janani Rangaswami. Closing gaps in the care of patients with heart-kidney disease: the time is now[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 257-258.
[9] Melanie McGinlay, Sam Straw, Jacob Jagger, Bako Nouri, John Gierula, Klaus K Witte. Impact of the COVID-19 pandemic on the management of chronic heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 271-276.
[10] Agata Bielecka-Dabrowa, Anna Cichocka-Radwan, Joanna Lewek, Filip Pawliczak, Marek Maciejewski, Maciej Banach. Cardiac manifestations of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 365-371.
[11] Paulino Alvarez, Alex Sianis, Jessica Brown, Abbas Ali, Alexandros Briasoulis. Chronic disease management in heart failure: focus on telemedicine and remote monitoring[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 403-413.
[12] Catrin Sohrabi, Syed Ahsan, Alexandros Briasoulis, Emmanuel Androulakis, Gerasimos Siasos, Neil T Srinivasan, Nikolaos Papageorgiou. Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 415-428.
[13] Mohd Aizuddin Mohd Zulastri, Muhammad Imran Hafidz, Muhammad Dzafir Ismail, Ahmad Syadi Mahmood Zuhdi. Hematocrit change as a predictor of readmission for decompensated heart failure: a retrospective single centre study[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 505-512.
[14] Martin A. Chacon-Portillo, Tushar Acharya, Rajesh Janardhanan. Imaging in heart failure with preserved ejection fraction: insights into echocardiography and cardiac magnetic resonance imaging[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 11-24.
[15] Kevin Bryan Lo, Hesam Mostafavi Toroghi, Grace Salacup, Jiahui Jiang, Ruchika Bhargav, Eduardo Quintero, Kira Balestrini, Anum Shahzad, Roy O. Mathew, Peter A McCullough, Janani Rangaswami. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 199-206.
No Suggested Reading articles found!